BioSpace News Archive

Exelixis, Inc. (Nasdaq: EXEL) and STORM Therapeutics (STORM) today announced that they have entered into an exclusive collaboration and license agreement under which the parties will discover and advance novel drug leads intended for the treatment of cancer.

RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced the award of a new SkinGun™ patent by the United States Patent and Trademark Office (US Patent No. 11,135,380).

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), and Augmenta Bioworks, a biotechnology company leveraging immune profiling technologies to enable breakthroughs in medicine, today announced the publication of a research paper highlighting positive preclinical study results of AUG-3387.

Veracyte, Inc. (Nasdaq: VCYT) announced that new data further validating the clinical utility of the company’s Decipher Prostate genomic test will be presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2021 taking place October 24-27, 2021, in Chicago.

Global health service company Cigna Corporation (NYSE:CI) will release its third quarter 2021 financial results on Thursday, November 4, 2021, and will host a conference call the same day.

ANGUS Chemical Company (“ANGUS” or “Company”), today announced plans to expand U.S. production capacity for its complete portfolio of TRIS AMINO™ tromethamine buffers.

Biotechnology company Tentarix Biotherapeutics LP today announced a $50 million Series A investment co-led by Versant Ventures and Samsara BioCapital.

Cerner Corporation (Nasdaq: CERN) today announced it will release its third quarter 2021 earnings results before the market opens Friday, Oct. 29.

CTI will launch the new initiative, focusing on offerings that will enhance cell and gene therapy capabilities.

The BioHive Summit, powered in partnership with BioUtah, on Nov. 12 will live stream a distinguished line-up of speakers and panelists from inside and outside Utah’s burgeoning life sciences industry (research, medical technology, diagnostics, health IT, digital health and biotechnology/biopharmaceutical) to discuss trends, challenges and the future of healthcare and Utah innovation.